Author

Shatarupa Bhattacharya

Indian Institute of Technology Kharagpur

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Genetics· 1 Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Approach:statistical model· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Assay:proteomics· 1

Frequent Co-Authors

Alok Chakraborty· 1 shared Arindam MondaliD· 1 shared Arjun Chatterjee· 1 shared Budhaditya MukherjeeiD· 1 shared Chiranjib BhowmickiD· 1 shared Indranath BanerjeeiD· 1 shared Indrani Das JanaiD· 1 shared Kawkab KanjoiD· 1 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMolecular Biology

Alok Chakraborty

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

GeneticsbioRxivPreprintAug 29, 2025

UCA1 lncRNA represses γ-globin expression by sequestering miR-148b, a key post-transcriptional regulator of BCL11A

Motiur Rahaman, Shatarupa Bhattacharya, Mandrita Mukherjee…·Nishant Chakravorty

The paper identifies UCA1 lncRNA as a ceRNA that sequesters miR-148b, increasing BCL11A expression and reducing γ-globin levels in adult erythroid cells.

DOI 10.1101/2025.08.29.673129

humanbulk RNA-seq

𝕏 PostBluesky

Molecular BiologyJournal of VirologyPeer-reviewedMar 26, 2025

Early 2022 breakthrough infection sera from India target the conserved cryptic class 5 epitope to counteract immune escape by SARS-CoV-2 variants

Indrani Das Jana, Kawkab Kanjo, Subhanita Roy…·Arindam Mondal

This study analyzes sera from Indian breakthrough infection patients vaccinated with ChAdOx, identifying broad neutralizing activity against SARS-CoV-2 variants, primarily targeting a conserved cryptic class 5 epitope.

1 citation

humanproteomics

𝕏 PostBluesky